First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer Post author: Post published:April 26, 2024 Post category:uncategorized The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer. You Might Also Like Union with labor dispute of its own threatens to cut off workers’ health benefits July 26, 2024 Sulfide-producing bacteria may explain lingering symptoms in Crohn’s disease December 19, 2024 WHO releases first-ever position paper on immunization products to protect infants against RSV May 30, 2025
WHO releases first-ever position paper on immunization products to protect infants against RSV May 30, 2025